[Reirradiation of brain metastasis: Review of the last five years].

La réirradiation des métastases cérébrales : revue des cinq dernières années.

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 28 06 2019
accepted: 15 07 2019
pubmed: 27 8 2019
medline: 9 10 2019
entrez: 27 8 2019
Statut: ppublish

Résumé

No recommandations have been established for reirradiation of brain metastases yet. The purpose of this review is to analyse the data of the five last years about the feasibility, efficacy and tolerance of reirradiation of brain metastases. Reirradiation can be 3D conformal or stereotactic. Whole brain irradiation seems appropriate for multiple brain metastases in order to obtain symptomatic relief, with or without supportive care. Stereotactic reirradiation has shown satisfying results in terms of overall survival, local control, without significant toxicity. Prospective trials are necessary in order to validate consensual recommandations.

Identifiants

pubmed: 31447342
pii: S1278-3218(19)30320-8
doi: 10.1016/j.canrad.2019.07.144
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

531-540

Informations de copyright

Copyright © 2019 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

M-N Nguyen (MN)

Département de radiothérapie, Centre de lutte contre le cancer Paul-Strauss, 3, rue de la Porte de l'hôpital, BP 42, 67065 Strasbourg cedex, France.

G Noel (G)

Département de radiothérapie, Centre de lutte contre le cancer Paul-Strauss, 3, rue de la Porte de l'hôpital, BP 42, 67065 Strasbourg cedex, France; Université de Strasbourg, CNRS, IPHC UMR 7178, Centre Paul Strauss, unicancer, 67000 Strasbourg, France.

D Antoni (D)

Département de radiothérapie, Centre de lutte contre le cancer Paul-Strauss, 3, rue de la Porte de l'hôpital, BP 42, 67065 Strasbourg cedex, France; Université de Strasbourg, CNRS, IPHC UMR 7178, Centre Paul Strauss, unicancer, 67000 Strasbourg, France. Electronic address: dantoni@strasbourg.unicancer.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH